| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 802 | 1.913 | 0 | 537 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 803 | 1.913 | 0 | 537 | 25 | 0 | 11 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.089 | 2.036 | 656 | 531 | 267 | 3.877 | 3.390 | 3.343 | 3.333 | 272 |
| Gross Profit/Loss - EUR | -285 | -124 | -656 | 7 | -241 | -3.877 | -3.380 | -3.343 | -3.333 | -272 |
| Net Profit/Loss - EUR | -344 | -148 | -656 | -9 | -241 | -3.877 | -3.380 | -3.343 | -3.333 | -272 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Derma Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 640 | 507 | 0 | 0 | 0 | 10.350 | 6.838 | 3.567 | 274 | 0 |
| Current Assets | 21.050 | 18.161 | 17.696 | 17.468 | 16.941 | 2.328 | 2.078 | 2.034 | 2.028 | 2.016 |
| Inventories | 17.140 | 15.146 | 15.287 | 14.616 | 14.333 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.497 | 889 | -25 | 99 | 97 | 95 | 93 | 93 | 93 | 92 |
| Cash | 2.413 | 2.125 | 2.433 | 2.753 | 2.511 | 2.233 | 1.985 | 1.941 | 1.935 | 1.924 |
| Shareholders Funds | -306 | -451 | -1.099 | -1.089 | -1.309 | -5.162 | -8.427 | -11.796 | -15.093 | -15.281 |
| Social Capital | 63 | 62 | 61 | 60 | 59 | 58 | 57 | 57 | 57 | 56 |
| Debts | 21.996 | 19.118 | 18.795 | 18.557 | 18.250 | 17.840 | 17.343 | 17.397 | 17.395 | 17.297 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Derma Med S.r.l.